| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.699 | 0.003 | 0.699 | GABA C receptor rho-3 antagonist | 0.62 0.005 CID_51818 0.531 0.018 CID_13332617 0.698 0.003 CID_154699680 0.671 0.004 CID_154699962 | ||
| 0.554 | 0.005 | 0.554 | DNA intercalator | 0.268 0.014 CID_51818 0.283 0.013 CID_13332617 0.527 0.005 CID_154699680 0.409 0.007 CID_154699962 | ||
| 0.549 | 0.016 | 0.549 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.435 0.072 CID_51818 0.382 0.117 CID_13332617 0.468 0.05 CID_154699680 0.534 0.021 CID_154699962 | ||
| 0.541 | 0.027 | 0.61 | Aldehyde oxidase inhibitor | 0.497 0.033 CID_51818 0.338 0.057 CID_13332617 0.607 0.018 CID_154699680 0.61 0.018 CID_154699962 | CID_154699962 | |
| 0.531 | 0.023 | 0.709 | 5 Hydroxytryptamine release stimulant | 0.529 0.023 CID_51818 0.263 0.083 CID_13332617 0.524 0.024 CID_154699680 0.709 0.006 CID_154699962 | CID_154699962 | |
| 0.511 | 0.023 | 0.511 | Aryl hydrocarbon receptor agonist | 0.385 0.04 CID_51818 0.173 0.119 CID_13332617 0.353 0.047 CID_154699680 0.369 0.044 CID_154699962 | ||
| 0.413 | 0.003 | 0.413 | GABA C receptor rho-2 antagonist | 0.339 0.004 CID_51818 0.216 0.021 CID_13332617 0.377 0.004 CID_154699680 0.315 0.005 CID_154699962 | ||
| 0.405 | 0.005 | 0.484 | Topoisomerase I inhibitor | 0.484 0.004 CID_51818 0.278 0.013 CID_13332617 0.452 0.004 CID_154699680 0.309 0.01 CID_154699962 | CID_51818 | |
| 0.421 | 0.023 | 0.432 | Dyrk kinase inhibitor | 0.245 0.074 CID_51818 0.381 0.03 CID_154699680 0.432 0.021 CID_154699962 | CID_154699962 | |
| 0.412 | 0.023 | 0.465 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.237 0.073 CID_51818 0.39 0.027 CID_154699680 0.465 0.017 CID_154699962 | CID_154699962 | |
| 0.399 | 0.01 | 0.522 | Topoisomerase II inhibitor | 0.358 0.013 CID_51818 0.337 0.014 CID_13332617 0.522 0.006 CID_154699680 0.41 0.01 CID_154699962 | CID_154699680 | |
| 0.436 | 0.058 | 0.554 | Calcium channel L-type activator | 0.512 0.023 CID_51818 0.313 0.146 CID_13332617 0.41 0.074 CID_154699680 0.554 0.012 CID_154699962 | CID_154699962 | |
| 0.454 | 0.081 | 0.744 | Caspase 9 stimulant | 0.535 0.048 CID_51818 0.345 0.149 CID_13332617 0.518 0.053 CID_154699680 0.744 0.019 CID_154699962 | CID_154699962 | |
| 0.421 | 0.066 | 0.428 | 5 Hydroxytryptamine release inhibitor | 0.35 0.116 CID_51818 0.27 0.202 CID_13332617 0.336 0.127 CID_154699680 0.428 0.062 CID_154699962 | CID_154699962 | |
| 0.384 | 0.032 | 0.483 | DNA damaging | 0.48 0.016 CID_51818 0.357 0.039 CID_13332617 0.482 0.015 CID_154699680 0.483 0.015 CID_154699962 | CID_154699962 | |
| 0.416 | 0.068 | 0.465 | Histamine release inhibitor | 0.408 0.072 CID_51818 0.234 0.168 CID_13332617 0.367 0.092 CID_154699680 0.465 0.043 CID_154699962 | CID_154699962 | |
| 0.346 | 0.005 | 0.346 | Ferrochelatase inhibitor | 0.239 0.015 CID_51818 0.159 0.034 CID_13332617 0.22 0.018 CID_154699680 0.156 0.035 CID_154699962 | ||
| 0.368 | 0.03 | 0.474 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.339 0.041 CID_51818 0.259 0.098 CID_154699680 0.474 0.01 CID_154699962 | CID_154699962 | |
| 0.384 | 0.068 | 0.384 | MAP kinase kinase 6 inhibitor | 0.286 0.149 CID_154699680 0.37 0.078 CID_154699962 | ||
| 0.298 | 0.004 | 0.309 | Photosensitizer | 0.309 0.004 CID_51818 0.215 0.01 CID_13332617 0.273 0.005 CID_154699680 0.211 0.011 CID_154699962 | CID_51818 | |
| 0.295 | 0.004 | 0.295 | GABA C receptor antagonist | 0.265 0.005 CID_51818 0.156 0.027 CID_13332617 0.275 0.005 CID_154699680 0.187 0.016 CID_154699962 | ||
| 0.312 | 0.022 | 0.312 | Protein kinase C nu inhibitor | 0.208 0.044 CID_154699680 0.289 0.026 CID_154699962 | ||
| 0.289 | 0.008 | 0.357 | Topoisomerase II alpha inhibitor | 0.182 0.018 CID_51818 0.17 0.02 CID_13332617 0.357 0.005 CID_154699680 0.291 0.008 CID_154699962 | CID_154699680 | |
| 0.281 | 0.004 | 0.281 | GABA C receptor rho-1 antagonist | 0.255 0.004 CID_51818 0.146 0.023 CID_13332617 0.249 0.004 CID_154699680 0.189 0.01 CID_154699962 | ||
| 0.312 | 0.035 | 0.419 | Peroxidase inhibitor | 0.285 0.04 CID_51818 0.127 0.093 CID_13332617 0.314 0.035 CID_154699680 0.419 0.018 CID_154699962 | CID_154699962 | |
| 0.303 | 0.032 | 0.532 | Tyrosine 3 hydroxylase inhibitor | 0.287 0.04 CID_51818 0.204 0.129 CID_13332617 0.348 0.016 CID_154699680 0.532 0.004 CID_154699962 | CID_154699962 | |
| 0.279 | 0.008 | 0.279 | 5 Hydroxytryptamine 3E antagonist | 0.22 0.036 CID_51818 0.169 0.138 CID_13332617 0.198 0.066 CID_154699680 0.216 0.041 CID_154699962 | ||
| 0.291 | 0.021 | 0.347 | Neurotrophic factor enhancer | 0.347 0.009 CID_51818 0.244 0.042 CID_13332617 0.294 0.02 CID_154699680 0.321 0.013 CID_154699962 | CID_51818 | |
| 0.271 | 0.004 | 0.271 | Antineoplastic alkaloid | 0.236 0.006 CID_51818 0.252 0.004 CID_13332617 0.249 0.005 CID_154699680 0.23 0.007 CID_154699962 | ||
| 0.313 | 0.046 | 0.346 | Superoxide dismutase inhibitor | 0.276 0.06 CID_51818 0.194 0.124 CID_13332617 0.262 0.067 CID_154699680 0.346 0.037 CID_154699962 | CID_154699962 | |
| 0.385 | 0.121 | 0.605 | Apoptosis agonist | 0.298 0.174 CID_51818 0.507 0.072 CID_13332617 0.548 0.061 CID_154699680 0.605 0.048 CID_154699962 | CID_154699962 | |
| 0.298 | 0.037 | 0.363 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.178 0.096 CID_51818 0.142 0.139 CID_154699680 0.363 0.02 CID_154699962 | CID_154699962 | |
| 0.326 | 0.067 | 0.375 | Calcium channel activator | 0.293 0.099 CID_51818 0.226 0.177 CID_13332617 0.302 0.09 CID_154699680 0.375 0.035 CID_154699962 | CID_154699962 | |
| 0.314 | 0.059 | 0.432 | Hypoxia-inducible factor 1 alpha inhibitor | 0.27 0.083 CID_51818 0.309 0.061 CID_13332617 0.432 0.023 CID_154699680 0.377 0.037 CID_154699962 | CID_154699680 | |
| 0.285 | 0.033 | 0.285 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.24 0.079 CID_51818 0.201 0.163 CID_154699680 0.219 0.117 CID_154699962 | ||
| 0.253 | 0.007 | 0.253 | Activin receptor-like kinase 4 inhibitor | 0.107 0.072 CID_13332617 0.116 0.057 CID_154699680 0.118 0.055 CID_154699962 | ||
| 0.27 | 0.029 | 0.27 | LIM domain kinase 1 inhibitor | 0.169 0.081 CID_51818 0.169 0.081 CID_154699680 0.157 0.091 CID_154699962 | ||
| 0.283 | 0.046 | 0.283 | Gastrin inhibitor | 0.251 0.078 CID_51818 0.235 0.098 CID_13332617 0.203 0.144 CID_154699680 0.182 0.175 CID_154699962 | ||
| 0.283 | 0.049 | 0.288 | Cyclic AMP phosphodiesterase inhibitor | 0.288 0.047 CID_51818 0.2 0.093 CID_13332617 0.257 0.06 CID_154699680 0.264 0.057 CID_154699962 | CID_51818 | |
| 0.263 | 0.037 | 0.358 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.309 0.021 CID_51818 0.234 0.05 CID_13332617 0.358 0.011 CID_154699680 0.327 0.017 CID_154699962 | CID_154699680 | |
| 0.238 | 0.015 | 0.279 | Mannose-6-phosphate isomerase inhibitor | 0.212 0.024 CID_51818 0.176 0.045 CID_13332617 0.278 0.007 CID_154699680 0.279 0.007 CID_154699962 | CID_154699962 | |
| 0.273 | 0.051 | 0.273 | 5 Hydroxytryptamine 1E antagonist | 0.184 0.15 CID_154699680 0.268 0.056 CID_154699962 | ||
| 0.231 | 0.011 | 0.27 | Telomerase inhibitor | 0.064 0.059 CID_51818 0.079 0.045 CID_13332617 0.247 0.01 CID_154699680 0.27 0.008 CID_154699962 | CID_154699962 | |
| 0.286 | 0.068 | 0.286 | Insulysin inhibitor | 0.249 0.098 CID_51818 0.269 0.08 CID_154699680 0.263 0.085 CID_154699962 | ||
| 0.24 | 0.023 | 0.24 | Activin receptor-like kinase 2 inhibitor | 0.167 0.055 CID_51818 0.147 0.069 CID_154699680 0.135 0.08 CID_154699962 | ||
| 0.259 | 0.042 | 0.352 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.133 0.102 CID_51818 0.352 0.026 CID_154699962 | CID_154699962 | |
| 0.244 | 0.037 | 0.244 | MAP kinase kinase 3 inhibitor | 0.194 0.142 CID_51818 0.183 0.179 CID_13332617 0.221 0.072 CID_154699680 0.203 0.113 CID_154699962 | ||
| 0.221 | 0.018 | 0.221 | Butyrylcholinesterase inhibitor | 0.101 0.061 CID_51818 0.103 0.06 CID_13332617 0.129 0.042 CID_154699680 | ||
| 0.268 | 0.065 | 0.268 | 5 Hydroxytryptamine uptake stimulant | 0.254 0.077 CID_51818 0.186 0.181 CID_13332617 0.236 0.095 CID_154699680 0.255 0.076 CID_154699962 | ||
| 0.204 | 0.007 | 0.204 | CYP2A6 inhibitor | 0.068 0.062 CID_51818 0.107 0.033 CID_154699680 0.066 0.065 CID_154699962 | ||
| 0.25 | 0.054 | 0.25 | MAP kinase kinase 2 inhibitor | 0.232 0.063 CID_51818 0.142 0.129 CID_154699962 | ||
| 0.25 | 0.057 | 0.25 | EphB2 antagonist | |||
| 0.217 | 0.025 | 0.258 | ATPase inhibitor | 0.175 0.064 CID_51818 0.258 0.012 CID_13332617 0.191 0.045 CID_154699680 0.153 0.097 CID_154699962 | CID_13332617 | |
| 0.249 | 0.061 | 0.458 | Pyruvate kinase inhibitor | 0.141 0.123 CID_51818 0.411 0.018 CID_154699680 0.458 0.013 CID_154699962 | CID_154699962 | |
| 0.284 | 0.097 | 0.328 | Apoptosis antagonist | 0.262 0.116 CID_51818 0.264 0.114 CID_13332617 0.31 0.079 CID_154699680 0.328 0.068 CID_154699962 | CID_154699962 | |
| 0.197 | 0.013 | 0.309 | Porphobilinogen synthase inhibitor | 0.309 0.005 CID_51818 0.072 0.054 CID_13332617 0.21 0.011 CID_154699680 0.2 0.012 CID_154699962 | CID_51818 | |
| 0.194 | 0.013 | 0.215 | Protein kinase C mu inhibitor | 0.09 0.067 CID_13332617 0.173 0.018 CID_154699680 0.215 0.01 CID_154699962 | CID_154699962 | |
| 0.201 | 0.021 | 0.209 | CF transmembrane conductance regulator agonist | 0.209 0.017 CID_51818 0.166 0.052 CID_13332617 0.166 0.052 CID_154699680 0.184 0.033 CID_154699962 | CID_51818 | |
| 0.195 | 0.015 | 0.195 | MAP kinase kinase 4 inhibitor | 0.185 0.021 CID_51818 0.161 0.044 CID_13332617 0.179 0.025 CID_154699680 0.161 0.043 CID_154699962 | ||
| 0.197 | 0.018 | 0.197 | GABA receptor agonist | 0.187 0.021 CID_51818 0.177 0.024 CID_154699680 0.136 0.044 CID_154699962 | ||
| 0.221 | 0.044 | 0.221 | Histone acetyltransferase inhibitor | 0.196 0.076 CID_154699680 0.185 0.092 CID_154699962 | ||
| 0.257 | 0.082 | 0.358 | Transcription factor STAT inhibitor | 0.186 0.158 CID_51818 0.29 0.061 CID_154699680 0.358 0.031 CID_154699962 | CID_154699962 | |
| 0.242 | 0.07 | 0.242 | Potassium channel blocker | |||
| 0.226 | 0.053 | 0.248 | Nitric-oxide synthase stimulant | 0.248 0.034 CID_51818 0.193 0.101 CID_13332617 0.209 0.075 CID_154699680 0.232 0.046 CID_154699962 | CID_51818 | |
| 0.204 | 0.034 | 0.204 | Toll-Like receptor 9 antagonist | 0.114 0.093 CID_154699680 0.127 0.08 CID_154699962 | ||
| 0.181 | 0.015 | 0.181 | TRPA1 agonist | 0.123 0.055 CID_51818 0.138 0.041 CID_154699680 0.158 0.026 CID_154699962 | ||
| 0.246 | 0.082 | 0.331 | Interleukin agonist | 0.331 0.035 CID_51818 0.172 0.147 CID_13332617 0.224 0.099 CID_154699680 0.16 0.158 CID_154699962 | CID_51818 | |
| 0.225 | 0.065 | 0.225 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.203 0.074 CID_154699962 | ||
| 0.274 | 0.115 | 0.301 | Prostaglandin dehydrogenase inhibitor | 0.298 0.103 CID_154699680 0.301 0.101 CID_154699962 | CID_154699962 | |
| 0.165 | 0.009 | 0.165 | Acetylcholine release stimulant | 0.148 0.018 CID_51818 0.131 0.033 CID_154699680 | ||
| 0.189 | 0.035 | 0.209 | Toll-Like receptor antagonist | 0.152 0.054 CID_51818 0.16 0.049 CID_154699680 0.209 0.028 CID_154699962 | CID_154699962 | |
| 0.254 | 0.101 | 0.297 | Streptokinase A inhibitor | 0.25 0.103 CID_154699680 0.297 0.08 CID_154699962 | CID_154699962 | |
| 0.173 | 0.021 | 0.252 | Protein kinase C gamma inhibitor | 0.176 0.02 CID_51818 0.097 0.082 CID_13332617 0.163 0.025 CID_154699680 0.252 0.006 CID_154699962 | CID_154699962 | |
| 0.174 | 0.024 | 0.174 | 5 Hydroxytryptamine 3A agonist | 0.111 0.064 CID_154699680 0.129 0.049 CID_154699962 | ||
| 0.201 | 0.051 | 0.201 | 3C-like protease (Human coronavirus) inhibitor | 0.139 0.121 CID_51818 | ||
| 0.211 | 0.061 | 0.211 | Focal adhesion kinase 2 inhibitor | 0.144 0.141 CID_51818 | ||
| 0.216 | 0.067 | 0.216 | Death-associated protein kinase 3 inhibitor | 0.147 0.127 CID_51818 0.176 0.091 CID_154699962 | ||
| 0.165 | 0.016 | 0.165 | Protein kinase C delta inhibitor | 0.132 0.03 CID_51818 0.113 0.041 CID_154699680 0.139 0.026 CID_154699962 | ||
| 0.166 | 0.019 | 0.166 | Sphingosine 1-phosphate receptor 2 agonist | 0.125 0.048 CID_51818 0.102 0.096 CID_13332617 0.119 0.056 CID_154699680 | ||
| 0.224 | 0.078 | 0.224 | MAP-kinase-activated kinase 5 inhibitor | 0.198 0.106 CID_154699962 | ||
| 0.183 | 0.038 | 0.183 | Acetylcholinesterase inhibitor | 0.103 0.099 CID_51818 0.117 0.081 CID_13332617 0.172 0.043 CID_154699680 0.107 0.093 CID_154699962 | ||
| 0.229 | 0.084 | 0.276 | DNA synthesis inhibitor | 0.262 0.059 CID_51818 0.249 0.067 CID_13332617 0.256 0.063 CID_154699680 0.276 0.053 CID_154699962 | CID_154699962 | |
| 0.196 | 0.052 | 0.317 | Heat shock protein 90 alpha antagonist | 0.135 0.104 CID_13332617 0.317 0.012 CID_154699680 0.189 0.057 CID_154699962 | CID_154699680 | |
| 0.218 | 0.076 | 0.363 | RNA-directed DNA polymerase inhibitor | 0.24 0.056 CID_51818 0.186 0.121 CID_13332617 0.252 0.048 CID_154699680 0.363 0.022 CID_154699962 | CID_154699962 | |
| 0.15 | 0.009 | 0.15 | Bromodomain-containing protein 2 inhibitor | 0.109 0.031 CID_51818 0.113 0.028 CID_154699680 0.111 0.03 CID_154699962 | ||
| 0.159 | 0.018 | 0.159 | Alcohol dehydrogenase inhibitor | 0.149 0.02 CID_51818 0.088 0.067 CID_13332617 0.129 0.029 CID_154699680 0.104 0.048 CID_154699962 | ||
| 0.283 | 0.142 | 0.615 | 15-Lipoxygenase inhibitor | 0.405 0.072 CID_154699680 0.615 0.022 CID_154699962 | CID_154699962 | |
| 0.153 | 0.013 | 0.153 | Histamine N-methyltransferase inhibitor | 0.113 0.035 CID_51818 0.089 0.057 CID_13332617 0.129 0.024 CID_154699680 0.08 0.066 CID_154699962 | ||
| 0.212 | 0.072 | 0.212 | Clk dual-specificity kinase inhibitor | |||
| 0.161 | 0.022 | 0.164 | Ca2+-transporting ATPase inhibitor | 0.153 0.037 CID_51818 0.157 0.028 CID_13332617 0.164 0.019 CID_154699680 0.162 0.021 CID_154699962 | CID_154699680 | |
| 0.188 | 0.049 | 0.307 | Interleukin 6 antagonist | 0.14 0.106 CID_51818 0.156 0.081 CID_13332617 0.215 0.033 CID_154699680 0.307 0.014 CID_154699962 | CID_154699962 | |
| 0.167 | 0.029 | 0.167 | Pregnane X receptor agonist | 0.138 0.078 CID_51818 0.133 0.09 CID_13332617 0.133 0.091 CID_154699680 0.124 0.117 CID_154699962 | ||
| 0.186 | 0.047 | 0.281 | Death-associated protein kinase 2 inhibitor | 0.161 0.084 CID_154699680 0.281 0.008 CID_154699962 | CID_154699962 | |
| 0.146 | 0.008 | 0.146 | Protein kinase B beta inhibitor | 0.124 0.014 CID_51818 0.07 0.058 CID_154699680 | ||
| 0.183 | 0.046 | 0.183 | CDC-like kinase 1 inhibitor | 0.121 0.094 CID_51818 0.168 0.057 CID_154699962 | ||
| 0.171 | 0.034 | 0.225 | MAP3K9 inhibitor | 0.211 0.011 CID_51818 0.136 0.082 CID_154699680 0.225 0.008 CID_154699962 | CID_154699962 | |
| 0.177 | 0.042 | 0.321 | Alpha-N-acetylglucosaminidase inhibitor | 0.321 0.014 CID_51818 0.185 0.039 CID_13332617 0.137 0.064 CID_154699680 0.116 0.082 CID_154699962 | CID_51818 | |
| 0.245 | 0.112 | 0.393 | 12-Lipoxygenase inhibitor | 0.382 0.044 CID_154699680 0.393 0.041 CID_154699962 | CID_154699962 | |
| 0.202 | 0.069 | 0.213 | I kappa B kinase epsilon inhibitor | 0.213 0.06 CID_51818 | CID_51818 | |
| 0.184 | 0.051 | 0.184 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.163 0.059 CID_154699962 | ||
| 0.177 | 0.045 | 0.177 | Cytokine production inhibitor | 0.159 0.056 CID_51818 | ||
| 0.267 | 0.136 | 0.387 | Immunosuppressant | 0.387 0.069 CID_13332617 0.329 0.098 CID_154699680 0.3 0.115 CID_154699962 | CID_13332617 | |
| 0.168 | 0.037 | 0.168 | Nav1.6 sodium channel blocker | 0.128 0.084 CID_51818 | ||
| 0.213 | 0.082 | 0.238 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.238 0.067 CID_154699962 | CID_154699962 | |
| 0.142 | 0.012 | 0.193 | Glutamate release inhibitor | 0.193 0.005 CID_51818 0.09 0.062 CID_13332617 0.108 0.032 CID_154699680 0.084 0.078 CID_154699962 | CID_51818 | |
| 0.196 | 0.067 | 0.248 | Growth factor agonist | 0.248 0.032 CID_51818 | CID_51818 | |
| 0.152 | 0.023 | 0.152 | Hedgehog signaling inhibitor | |||
| 0.189 | 0.061 | 0.375 | Mcl-1 antagonist | 0.128 0.114 CID_13332617 0.335 0.017 CID_154699680 0.375 0.013 CID_154699962 | CID_154699962 | |
| 0.157 | 0.03 | 0.203 | Interleukin 8 antagonist | 0.117 0.065 CID_51818 0.14 0.041 CID_154699680 0.203 0.012 CID_154699962 | CID_154699962 | |
| 0.179 | 0.052 | 0.179 | Cyclin-dependent kinase 8 inhibitor | 0.158 0.072 CID_51818 0.126 0.108 CID_13332617 | ||
| 0.187 | 0.06 | 0.196 | Succinate dehydrogenase inhibitor | 0.196 0.052 CID_51818 0.176 0.073 CID_154699680 0.173 0.077 CID_154699962 | CID_51818 | |
| 0.147 | 0.021 | 0.274 | Protein kinase C zeta inhibitor | 0.139 0.023 CID_51818 0.092 0.062 CID_13332617 0.145 0.021 CID_154699680 0.274 0.006 CID_154699962 | CID_154699962 | |
| 0.132 | 0.006 | 0.202 | Topoisomerase II beta inhibitor | 0.202 0.004 CID_51818 0.062 0.021 CID_13332617 0.155 0.005 CID_154699680 0.123 0.007 CID_154699962 | CID_51818 | |
| 0.135 | 0.009 | 0.153 | Protein kinase C eta inhibitor | 0.108 0.015 CID_51818 0.066 0.03 CID_13332617 0.127 0.011 CID_154699680 0.153 0.007 CID_154699962 | CID_154699962 | |
| 0.144 | 0.019 | 0.202 | NADH dehydrogenase inhibitor | 0.202 0.01 CID_51818 0.138 0.021 CID_13332617 0.133 0.023 CID_154699680 0.099 0.045 CID_154699962 | CID_51818 | |
| 0.132 | 0.009 | 0.132 | Transforming growth factor antagonist | 0.066 0.054 CID_154699680 | ||
| 0.177 | 0.054 | 0.177 | Neurotensin receptor agonist | 0.167 0.067 CID_51818 0.163 0.075 CID_154699680 0.141 0.125 CID_154699962 | ||
| 0.16 | 0.039 | 0.16 | Platelet activating factor antagonist | |||
| 0.13 | 0.011 | 0.152 | Granulocyte macrophage colony stimulating factor agonist | 0.152 0.005 CID_51818 0.108 0.026 CID_154699680 0.087 0.057 CID_154699962 | CID_51818 | |
| 0.211 | 0.094 | 0.448 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.429 0.032 CID_154699680 0.448 0.028 CID_154699962 | CID_154699962 | |
| 0.187 | 0.076 | 0.292 | DNA methyltransferase I inhibitor | 0.205 0.067 CID_51818 0.292 0.029 CID_154699680 0.269 0.039 CID_154699962 | CID_154699680 | |
| 0.242 | 0.131 | 0.357 | Cholesterol antagonist | 0.357 0.061 CID_51818 0.188 0.176 CID_13332617 0.235 0.136 CID_154699680 0.187 0.177 CID_154699962 | CID_51818 | |
| 0.118 | 0.008 | 0.122 | Dihydroorotate dehydrogenase inhibitor | 0.122 0.007 CID_51818 0.11 0.009 CID_154699680 0.048 0.039 CID_154699962 | CID_51818 | |
| 0.111 | 0.002 | 0.111 | Estrogen-related receptor beta antagonist | 0.096 0.003 CID_51818 0.07 0.004 CID_13332617 0.093 0.003 CID_154699680 0.035 0.017 CID_154699962 | ||
| 0.121 | 0.012 | 0.121 | GABA A receptor antagonist | 0.077 0.023 CID_51818 0.067 0.027 CID_154699680 0.072 0.024 CID_154699962 | ||
| 0.167 | 0.058 | 0.303 | Heat shock protein 90 antagonist | 0.167 0.058 CID_13332617 0.303 0.01 CID_154699680 0.172 0.054 CID_154699962 | CID_154699680 | |
| 0.128 | 0.021 | 0.128 | GABA A receptor agonist | 0.116 0.026 CID_51818 0.109 0.031 CID_154699680 0.079 0.065 CID_154699962 | ||
| 0.123 | 0.017 | 0.123 | Protein kinase B alpha inhibitor | 0.065 0.053 CID_51818 | ||
| 0.233 | 0.128 | 0.299 | Caspase 3 stimulant | 0.299 0.079 CID_51818 0.2 0.169 CID_13332617 0.239 0.123 CID_154699680 0.244 0.117 CID_154699962 | CID_51818 | |
| 0.122 | 0.018 | 0.144 | Phenylalanine 4-hydroxylase inhibitor | 0.144 0.013 CID_51818 0.08 0.037 CID_13332617 0.114 0.02 CID_154699680 0.114 0.02 CID_154699962 | CID_51818 | |
| 0.117 | 0.013 | 0.117 | GABA receptor antagonist | 0.078 0.022 CID_51818 0.076 0.023 CID_154699680 0.083 0.02 CID_154699962 | ||
| 0.119 | 0.016 | 0.119 | Benzodiazepine agonist | 0.098 0.027 CID_51818 0.08 0.039 CID_154699680 0.063 0.062 CID_154699962 | ||
| 0.115 | 0.012 | 0.115 | Cannabinoid CB1 receptor antagonist | 0.065 0.039 CID_51818 | ||
| 0.128 | 0.026 | 0.191 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.176 0.013 CID_51818 0.087 0.046 CID_13332617 0.191 0.01 CID_154699680 0.154 0.017 CID_154699962 | CID_154699680 | |
| 0.114 | 0.012 | 0.19 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.19 0.007 CID_51818 0.114 0.012 CID_13332617 0.09 0.017 CID_154699680 0.054 0.042 CID_154699962 | CID_51818 | |
| 0.168 | 0.067 | 0.176 | Arachidonic acid antagonist | 0.155 0.083 CID_51818 0.165 0.071 CID_13332617 0.17 0.065 CID_154699680 0.176 0.058 CID_154699962 | CID_154699962 | |
| 0.137 | 0.036 | 0.137 | Transcription factor STAT6 inhibitor | 0.121 0.058 CID_154699680 0.113 0.074 CID_154699962 | ||
| 0.207 | 0.107 | 0.207 | Neuropeptide Y2 antagonist | |||
| 0.119 | 0.019 | 0.153 | Glycine receptor antagonist | 0.1 0.032 CID_51818 0.105 0.028 CID_13332617 0.092 0.04 CID_154699680 0.153 0.007 CID_154699962 | CID_154699962 | |
| 0.179 | 0.08 | 0.179 | CDC-like kinase 4 inhibitor | |||
| 0.183 | 0.085 | 0.201 | Non-steroidal antiinflammatory agent | 0.201 0.07 CID_51818 0.167 0.098 CID_154699680 0.153 0.111 CID_154699962 | CID_51818 | |
| 0.131 | 0.034 | 0.211 | HIV-1 integrase (Overall Integration) inhibitor | 0.211 0.009 CID_51818 0.127 0.036 CID_154699680 0.144 0.027 CID_154699962 | CID_51818 | |
| 0.106 | 0.011 | 0.106 | Aryl hydrocarbon receptor antagonist | 0.073 0.034 CID_51818 0.08 0.027 CID_154699680 0.078 0.029 CID_154699962 | ||
| 0.1 | 0.007 | 0.1 | Corticotropin releasing factor 2 receptor antagonist | 0.068 0.032 CID_154699680 | ||
| 0.116 | 0.023 | 0.116 | Cannabinoid receptor antagonist | |||
| 0.128 | 0.035 | 0.179 | Creatine kinase inhibitor | 0.118 0.043 CID_51818 0.103 0.056 CID_13332617 0.172 0.016 CID_154699680 0.179 0.015 CID_154699962 | CID_154699962 | |
| 0.183 | 0.091 | 0.183 | Psychostimulant | 0.18 0.092 CID_51818 0.162 0.106 CID_154699680 0.149 0.117 CID_154699962 | ||
| 0.111 | 0.019 | 0.147 | D-Ala-D-Ala ligase inhibitor | 0.09 0.044 CID_51818 0.081 0.065 CID_13332617 0.111 0.019 CID_154699680 0.147 0.006 CID_154699962 | CID_154699962 | |
| 0.183 | 0.091 | 0.272 | DNA methylase inhibitor | 0.209 0.073 CID_51818 0.272 0.038 CID_154699680 0.242 0.053 CID_154699962 | CID_154699680 | |
| 0.232 | 0.14 | 0.383 | Transcription factor NF kappa B inhibitor | 0.229 0.143 CID_51818 0.278 0.108 CID_13332617 0.33 0.083 CID_154699680 0.383 0.067 CID_154699962 | CID_154699962 | |
| 0.169 | 0.078 | 0.169 | Tumour necrosis factor antagonist | 0.142 0.111 CID_51818 0.166 0.081 CID_154699680 0.135 0.12 CID_154699962 | ||
| 0.132 | 0.042 | 0.157 | GABA C receptor agonist | 0.157 0.031 CID_51818 0.111 0.056 CID_154699680 0.107 0.06 CID_154699962 | CID_51818 | |
| 0.114 | 0.026 | 0.114 | 5 Hydroxytryptamine 1F antagonist | 0.105 0.029 CID_154699962 | ||
| 0.101 | 0.013 | 0.127 | Protein kinase C beta inhibitor | 0.096 0.015 CID_51818 0.096 0.015 CID_154699680 0.127 0.006 CID_154699962 | CID_154699962 | |
| 0.137 | 0.051 | 0.137 | Beta amyloid protein antagonist | |||
| 0.09 | 0.004 | 0.09 | Benzodiazepine antagonist | 0.058 0.015 CID_51818 0.054 0.02 CID_154699680 | ||
| 0.101 | 0.015 | 0.101 | 5 Hydroxytryptamine 5A antagonist | 0.08 0.024 CID_154699680 0.058 0.049 CID_154699962 | ||
| 0.119 | 0.033 | 0.174 | Triose-phosphate isomerase inhibitor | 0.174 0.014 CID_51818 0.104 0.044 CID_13332617 0.098 0.049 CID_154699680 0.112 0.037 CID_154699962 | CID_51818 | |
| 0.133 | 0.049 | 0.231 | Cystathionine beta-synthase inhibitor | 0.113 0.064 CID_51818 0.093 0.085 CID_13332617 0.229 0.019 CID_154699680 0.231 0.018 CID_154699962 | CID_154699962 | |
| 0.127 | 0.043 | 0.17 | Estrogen antagonist | 0.122 0.052 CID_13332617 0.17 0.018 CID_154699680 0.157 0.021 CID_154699962 | CID_154699680 | |
| 0.124 | 0.04 | 0.155 | Adenylate kinase inhibitor | 0.155 0.025 CID_51818 0.118 0.045 CID_13332617 0.107 0.057 CID_154699680 0.101 0.065 CID_154699962 | CID_51818 | |
| 0.102 | 0.018 | 0.102 | Biliverdin reductase inhibitor | 0.099 0.019 CID_51818 0.079 0.027 CID_13332617 0.067 0.034 CID_154699680 | ||
| 0.097 | 0.015 | 0.097 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.077 0.042 CID_51818 0.076 0.045 CID_13332617 | ||
| 0.097 | 0.015 | 0.113 | MAP kinase kinase 7 inhibitor | 0.105 0.009 CID_51818 0.086 0.032 CID_13332617 0.105 0.009 CID_154699680 0.113 0.005 CID_154699962 | CID_154699962 | |
| 0.177 | 0.095 | 0.177 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.09 | 0.01 | 0.09 | Transcription factor RelA inhibitor | 0.061 0.053 CID_51818 0.067 0.035 CID_13332617 0.082 0.015 CID_154699680 0.067 0.035 CID_154699962 | ||
| 0.1 | 0.021 | 0.1 | Glycine receptor agonist | 0.082 0.036 CID_51818 0.089 0.029 CID_13332617 0.096 0.023 CID_154699680 | ||
| 0.095 | 0.016 | 0.095 | 5 Hydroxytryptamine 5 antagonist | 0.069 0.027 CID_154699680 | ||
| 0.096 | 0.017 | 0.096 | 5 Hydroxytryptamine 3 agonist | 0.065 0.041 CID_51818 0.057 0.055 CID_154699680 | ||
| 0.157 | 0.08 | 0.19 | Cyclin-dependent kinase 3 inhibitor | 0.19 0.04 CID_51818 0.141 0.118 CID_154699680 0.179 0.049 CID_154699962 | CID_51818 | |
| 0.104 | 0.028 | 0.107 | mTOR complex 2 inhibitor | 0.107 0.026 CID_51818 0.078 0.073 CID_154699680 | CID_51818 | |
| 0.118 | 0.043 | 0.118 | Pim-1 kinase inhibitor | 0.091 0.066 CID_51818 | ||
| 0.185 | 0.11 | 0.199 | Antiamyloidogenic | 0.194 0.104 CID_51818 0.199 0.101 CID_154699680 0.18 0.114 CID_154699962 | CID_154699680 | |
| 0.111 | 0.036 | 0.111 | Pim-3 kinase inhibitor | 0.083 0.07 CID_51818 | ||
| 0.145 | 0.071 | 0.16 | Adenylate cyclase stimulant | 0.16 0.047 CID_51818 0.142 0.078 CID_13332617 0.141 0.079 CID_154699680 0.16 0.047 CID_154699962 | CID_154699962 | |
| 0.157 | 0.082 | 0.157 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.088 | 0.014 | 0.088 | Toll-Like receptor 8 antagonist | 0.065 0.027 CID_51818 | ||
| 0.203 | 0.13 | 0.285 | Transcription factor STAT3 inhibitor | 0.19 0.148 CID_51818 0.235 0.096 CID_154699680 0.285 0.061 CID_154699962 | CID_154699962 | |
| 0.109 | 0.035 | 0.109 | Phosphodiesterase I inhibitor | 0.1 0.045 CID_51818 | ||
| 0.094 | 0.021 | 0.126 | GABA B receptor agonist | 0.092 0.024 CID_51818 0.096 0.019 CID_154699680 0.126 0.006 CID_154699962 | CID_154699962 | |
| 0.1 | 0.027 | 0.13 | Estrogen receptor alpha antagonist | 0.079 0.049 CID_51818 0.09 0.035 CID_13332617 0.13 0.016 CID_154699680 0.119 0.019 CID_154699962 | CID_154699680 | |
| 0.119 | 0.047 | 0.168 | Beta glucuronidase inhibitor | 0.104 0.064 CID_51818 0.096 0.077 CID_13332617 0.142 0.029 CID_154699680 0.168 0.018 CID_154699962 | CID_154699962 | |
| 0.085 | 0.013 | 0.085 | Transforming growth factor beta 1 antagonist | |||
| 0.087 | 0.015 | 0.092 | Fatty acid synthase inhibitor | 0.052 0.047 CID_13332617 0.092 0.014 CID_154699680 0.071 0.025 CID_154699962 | CID_154699680 | |
| 0.145 | 0.076 | 0.156 | MAP kinase 3 inhibitor | 0.156 0.058 CID_51818 | CID_51818 | |
| 0.113 | 0.043 | 0.196 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.196 0.016 CID_51818 0.085 0.073 CID_13332617 | CID_51818 | |
| 0.166 | 0.097 | 0.17 | Anesthetic general | 0.17 0.094 CID_51818 0.147 0.117 CID_13332617 | CID_51818 | |
| 0.133 | 0.064 | 0.133 | Cyclooxygenase 3 inhibitor | 0.129 0.068 CID_51818 0.12 0.077 CID_154699680 0.114 0.084 CID_154699962 | ||
| 0.147 | 0.079 | 0.147 | Cholinergic | 0.116 0.114 CID_154699680 | ||
| 0.114 | 0.047 | 0.175 | UDP-glucose 4-epimerase inhibitor | 0.175 0.022 CID_51818 0.113 0.049 CID_13332617 0.111 0.05 CID_154699680 0.124 0.041 CID_154699962 | CID_51818 | |
| 0.129 | 0.062 | 0.169 | Aldehyde dehydrogenase inhibitor | 0.169 0.038 CID_51818 0.108 0.085 CID_154699680 0.112 0.08 CID_154699962 | CID_51818 | |
| 0.116 | 0.05 | 0.146 | DOPA decarboxylase inhibitor | 0.123 0.042 CID_51818 0.137 0.029 CID_154699680 0.146 0.023 CID_154699962 | CID_154699962 | |
| 0.141 | 0.076 | 0.141 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.163 | 0.099 | 0.336 | Amyloid beta aggregation inhibitor | 0.152 0.106 CID_51818 0.261 0.054 CID_154699680 0.336 0.038 CID_154699962 | CID_154699962 | |
| 0.135 | 0.071 | 0.135 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.116 0.085 CID_154699680 0.102 0.099 CID_154699962 | ||
| 0.101 | 0.038 | 0.12 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.112 0.029 CID_51818 0.081 0.062 CID_154699680 0.12 0.025 CID_154699962 | CID_154699962 | |
| 0.082 | 0.02 | 0.082 | Phosphodiesterase 4C inhibitor | 0.061 0.034 CID_51818 | ||
| 0.136 | 0.075 | 0.136 | Glycogen synthase kinase-3 alpha inhibitor | 0.106 0.097 CID_51818 0.112 0.091 CID_154699962 | ||
| 0.201 | 0.14 | 0.479 | Lipoxygenase inhibitor | 0.316 0.064 CID_154699680 0.479 0.021 CID_154699962 | CID_154699962 | |
| 0.071 | 0.011 | 0.071 | Dihydroorotase inhibitor | 0.05 0.024 CID_51818 0.048 0.027 CID_154699680 | ||
| 0.108 | 0.049 | 0.145 | Estrogen receptor beta antagonist | 0.102 0.06 CID_13332617 0.145 0.017 CID_154699680 0.131 0.023 CID_154699962 | CID_154699680 | |
| 0.144 | 0.086 | 0.189 | Hexokinase inhibitor | 0.184 0.046 CID_51818 0.169 0.059 CID_154699680 0.189 0.042 CID_154699962 | CID_154699962 | |
| 0.085 | 0.027 | 0.085 | Phospholipase D inhibitor | 0.074 0.044 CID_51818 | ||
| 0.091 | 0.034 | 0.091 | CC chemokine 5 receptor agonist | 0.079 0.069 CID_154699680 0.088 0.04 CID_154699962 | ||
| 0.08 | 0.024 | 0.08 | Glutamate (mGluR6) antagonist | 0.078 0.026 CID_51818 0.067 0.045 CID_13332617 0.065 0.052 CID_154699680 | ||
| 0.079 | 0.023 | 0.079 | Phosphodiesterase 1B inhibitor | 0.065 0.035 CID_51818 | ||
| 0.143 | 0.087 | 0.154 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.154 0.066 CID_154699962 | CID_154699962 | |
| 0.118 | 0.063 | 0.118 | 5 Hydroxytryptamine 2B antagonist | 0.102 0.081 CID_154699680 0.105 0.078 CID_154699962 | ||
| 0.068 | 0.013 | 0.068 | Adenylate cyclase 1 inhibitor | 0.05 0.026 CID_13332617 0.043 0.037 CID_154699680 | ||
| 0.124 | 0.07 | 0.124 | Cathepsin H inhibitor | |||
| 0.105 | 0.051 | 0.105 | Electrolyte absorption antagonist | |||
| 0.103 | 0.05 | 0.103 | Potassium channel (Voltage-sensitive) activator | |||
| 0.058 | 0.005 | 0.058 | Benzodiazepine receptor peripheral-type antagonist | 0.037 0.019 CID_51818 | ||
| 0.109 | 0.056 | 0.167 | Carbonic anhydrase XV inhibitor | 0.167 0.025 CID_51818 0.088 0.087 CID_154699680 0.093 0.078 CID_154699962 | CID_51818 | |
| 0.122 | 0.069 | 0.123 | Sphingosine 1-phosphate receptor 4 antagonist | 0.123 0.066 CID_51818 | CID_51818 | |
| 0.08 | 0.028 | 0.08 | Potassium channel (ATP-sensitive) blocker | |||
| 0.062 | 0.01 | 0.063 | Guanylate cyclase inhibitor | 0.063 0.009 CID_51818 0.044 0.028 CID_13332617 0.048 0.024 CID_154699680 | CID_51818 | |
| 0.085 | 0.033 | 0.085 | Toll-Like receptor 7 antagonist | |||
| 0.091 | 0.04 | 0.108 | Macrophage migration inhibitory factor inhibitor | 0.108 0.031 CID_51818 0.088 0.043 CID_154699680 | CID_51818 | |
| 0.121 | 0.07 | 0.137 | DNA repair enzyme inhibitor | 0.137 0.046 CID_51818 0.112 0.091 CID_154699680 0.133 0.051 CID_154699962 | CID_51818 | |
| 0.137 | 0.086 | 0.137 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.074 | 0.024 | 0.088 | Cyclin D1 inhibitor | 0.07 0.028 CID_51818 0.088 0.013 CID_154699962 | CID_154699962 | |
| 0.069 | 0.019 | 0.084 | Aconitate hydratase inhibitor | 0.084 0.012 CID_51818 0.052 0.036 CID_154699680 | CID_51818 | |
| 0.071 | 0.022 | 0.071 | Protein kinase C theta inhibitor | |||
| 0.069 | 0.02 | 0.069 | 5 Hydroxytryptamine 7 agonist | 0.056 0.038 CID_154699962 | ||
| 0.09 | 0.041 | 0.09 | Caspase 7 inhibitor | 0.077 0.07 CID_51818 | ||
| 0.059 | 0.011 | 0.059 | Alpha 1d adrenoreceptor agonist | |||
| 0.1 | 0.052 | 0.1 | Falcipain 2 inhibitor | |||
| 0.097 | 0.049 | 0.166 | Androgen antagonist | 0.08 0.066 CID_154699680 0.166 0.019 CID_154699962 | CID_154699962 | |
| 0.136 | 0.089 | 0.136 | Neuropeptide Y1 antagonist | |||
| 0.072 | 0.025 | 0.072 | Calcium channel P-type blocker | |||
| 0.077 | 0.031 | 0.077 | Glutamate (mGluR7) antagonist | |||
| 0.1 | 0.054 | 0.1 | Falcipain inhibitor | |||
| 0.11 | 0.066 | 0.149 | Alpha 2b adrenoreceptor antagonist | 0.149 0.039 CID_154699962 | CID_154699962 | |
| 0.069 | 0.025 | 0.069 | Phosphodiesterase 1A inhibitor | |||
| 0.068 | 0.024 | 0.068 | Cannabinoid CB2 receptor antagonist | 0.043 0.042 CID_51818 | ||
| 0.099 | 0.056 | 0.144 | Prolactin inhibitor | 0.122 0.037 CID_51818 0.109 0.047 CID_154699680 0.144 0.025 CID_154699962 | CID_154699962 | |
| 0.1 | 0.056 | 0.103 | Lanosterol 14 alpha demethylase inhibitor | 0.103 0.052 CID_51818 | CID_51818 | |
| 0.104 | 0.061 | 0.104 | Protein kinase (CK2) inhibitor | 0.097 0.066 CID_51818 0.101 0.063 CID_154699680 0.092 0.071 CID_154699962 | ||
| 0.124 | 0.08 | 0.124 | Sodium channel (voltage-gated) blocker | |||
| 0.079 | 0.036 | 0.079 | Phosphodiesterase 4B inhibitor | 0.064 0.051 CID_51818 | ||
| 0.056 | 0.013 | 0.056 | Dihydrofolate reductase inhibitor | 0.043 0.031 CID_51818 | ||
| 0.08 | 0.037 | 0.084 | Sphingosine 1-phosphate receptor 4 agonist | 0.084 0.034 CID_51818 | CID_51818 | |
| 0.136 | 0.093 | 0.144 | Heat shock protein 70 antagonist | 0.129 0.128 CID_51818 0.144 0.06 CID_154699962 | CID_154699962 | |
| 0.055 | 0.013 | 0.055 | Retinoid X alpha receptor agonist | 0.042 0.018 CID_51818 0.041 0.019 CID_154699680 | ||
| 0.116 | 0.075 | 0.116 | MAP kinase 12 inhibitor | 0.102 0.095 CID_154699962 | ||
| 0.057 | 0.016 | 0.064 | Cytokine production stimulant | 0.064 0.01 CID_51818 | CID_51818 | |
| 0.064 | 0.023 | 0.067 | Pregnane X receptor antagonist | 0.064 0.022 CID_154699680 0.067 0.018 CID_154699962 | CID_154699962 | |
| 0.14 | 0.1 | 0.14 | CDC-like kinase 2 inhibitor | |||
| 0.099 | 0.059 | 0.107 | Interleukin 1 beta converting enzyme inhibitor | 0.107 0.048 CID_51818 0.085 0.081 CID_154699680 | CID_51818 | |
| 0.078 | 0.039 | 0.078 | I kappa B kinase 1 inhibitor | 0.07 0.048 CID_51818 | ||
| 0.054 | 0.016 | 0.089 | GABA B receptor antagonist | 0.048 0.022 CID_51818 0.045 0.025 CID_154699680 0.089 0.005 CID_154699962 | CID_154699962 | |
| 0.26 | 0.222 | 0.26 | MAP kinase 1 inhibitor | |||
| 0.084 | 0.046 | 0.084 | Fibroblast growth factor 3 antagonist | |||
| 0.05 | 0.012 | 0.05 | Retinoid X receptor antagonist | 0.043 0.02 CID_51818 0.048 0.015 CID_154699680 | ||
| 0.119 | 0.081 | 0.321 | Tubulin antagonist | 0.222 0.031 CID_154699680 0.321 0.017 CID_154699962 | CID_154699962 | |
| 0.069 | 0.031 | 0.077 | Phosphodiesterase 1C inhibitor | 0.077 0.022 CID_51818 | CID_51818 | |
| 0.06 | 0.024 | 0.06 | Immunoglobulin Fc receptor antagonist | 0.056 0.035 CID_51818 | ||
| 0.069 | 0.033 | 0.096 | Prostaglandin F2 alpha antagonist | 0.061 0.045 CID_51818 0.069 0.033 CID_13332617 0.096 0.013 CID_154699680 | CID_154699680 | |
| 0.106 | 0.07 | 0.166 | Cyclin-dependent kinase 5 inhibitor | 0.166 0.033 CID_154699962 | CID_154699962 | |
| 0.073 | 0.038 | 0.073 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.063 | 0.028 | 0.063 | Pim-2 kinase inhibitor | 0.052 0.041 CID_51818 | ||
| 0.099 | 0.064 | 0.276 | Carbonic anhydrase III inhibitor | 0.142 0.032 CID_51818 0.127 0.039 CID_154699680 0.276 0.007 CID_154699962 | CID_154699962 | |
| 0.054 | 0.019 | 0.054 | Geranyltranstransferase inhibitor | 0.046 0.027 CID_51818 0.053 0.02 CID_154699680 | ||
| 0.099 | 0.064 | 0.13 | Anabolic | 0.097 0.066 CID_51818 0.111 0.048 CID_13332617 0.111 0.049 CID_154699680 0.13 0.03 CID_154699962 | CID_154699962 | |
| 0.049 | 0.015 | 0.061 | Inosine monophosphate dehydrogenase inhibitor | 0.038 0.024 CID_154699680 0.061 0.01 CID_154699962 | CID_154699962 | |
| 0.054 | 0.02 | 0.054 | Purinergic P2X4 antagonist | 0.046 0.031 CID_51818 0.042 0.041 CID_154699962 | ||
| 0.075 | 0.042 | 0.19 | Cyclin B3 inhibitor | 0.19 0.007 CID_154699962 | CID_154699962 | |
| 0.044 | 0.011 | 0.044 | Retinoid X alpha receptor antagonist | 0.037 0.018 CID_51818 0.04 0.014 CID_154699680 | ||
| 0.06 | 0.027 | 0.06 | Lysine-specific demethylase 1A inhibitor | 0.057 0.033 CID_51818 | ||
| 0.084 | 0.051 | 0.19 | T cell inhibitor | 0.078 0.074 CID_13332617 0.095 0.03 CID_154699680 0.19 0.008 CID_154699962 | CID_154699962 | |
| 0.11 | 0.078 | 0.177 | Alkylator | 0.127 0.062 CID_51818 0.168 0.038 CID_13332617 0.177 0.034 CID_154699680 0.172 0.036 CID_154699962 | CID_154699680 | |
| 0.065 | 0.033 | 0.065 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.066 | 0.034 | 0.083 | Androgen agonist | 0.062 0.039 CID_51818 0.063 0.037 CID_13332617 0.064 0.037 CID_154699680 0.083 0.023 CID_154699962 | CID_154699962 | |
| 0.054 | 0.022 | 0.062 | Phosphodiesterase 3B inhibitor | 0.062 0.019 CID_51818 | CID_51818 | |
| 0.042 | 0.01 | 0.042 | Purinergic P2Y14 antagonist | 0.037 0.013 CID_51818 | ||
| 0.229 | 0.198 | 0.39 | Antibacterial | 0.376 0.088 CID_13332617 0.347 0.104 CID_154699680 0.39 0.082 CID_154699962 | CID_154699962 | |
| 0.094 | 0.064 | 0.094 | Platelet activating factor alpha antagonist | |||
| 0.092 | 0.062 | 0.092 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.078 | 0.049 | 0.078 | Phosphodiesterase 4D inhibitor | 0.071 0.054 CID_51818 | ||
| 0.071 | 0.042 | 0.076 | Protein kinase C alpha inhibitor | 0.076 0.037 CID_51818 0.069 0.045 CID_154699962 | CID_51818 | |
| 0.034 | 0.005 | 0.034 | Imidazoline I1 receptor antagonist | |||
| 0.044 | 0.015 | 0.044 | Estrogen-related receptor alpha antagonist | 0.032 0.023 CID_51818 0.035 0.02 CID_154699680 | ||
| 0.072 | 0.043 | 0.072 | CDC7 inhibitor | |||
| 0.065 | 0.037 | 0.077 | Purinergic P2X1 antagonist | 0.072 0.03 CID_51818 0.057 0.049 CID_13332617 0.077 0.027 CID_154699680 0.06 0.044 CID_154699962 | CID_154699680 | |
| 0.116 | 0.087 | 0.123 | Antibacterial (Helicobacter pylori) | 0.114 0.09 CID_154699680 0.123 0.076 CID_154699962 | CID_154699962 | |
| 0.074 | 0.045 | 0.074 | Orexin receptor 1 antagonist | |||
| 0.094 | 0.066 | 0.094 | Phosphodiesterase 6D inhibitor | 0.094 0.064 CID_51818 0.091 0.073 CID_154699962 | ||
| 0.095 | 0.068 | 0.175 | MAO A inhibitor | 0.175 0.035 CID_154699680 0.174 0.035 CID_154699962 | CID_154699680 | |
| 0.095 | 0.068 | 0.095 | Nitric-oxide synthase inhibitor | |||
| 0.057 | 0.03 | 0.057 | 5 Hydroxytryptamine 2 agonist | |||
| 0.051 | 0.024 | 0.051 | Benzodiazepine inverse agonist | 0.045 0.036 CID_51818 | ||
| 0.055 | 0.028 | 0.055 | Potassium channel (Inward rectifier) blocker | |||
| 0.071 | 0.044 | 0.071 | p38 MAP kinase inhibitor | |||
| 0.126 | 0.1 | 0.136 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.136 0.087 CID_154699962 | CID_154699962 | |
| 0.047 | 0.021 | 0.05 | Angiotensin AT1 receptor antagonist | 0.05 0.017 CID_51818 | CID_51818 | |
| 0.201 | 0.175 | 0.289 | Vasodilator, peripheral | 0.289 0.102 CID_51818 0.255 0.124 CID_154699962 | CID_51818 | |
| 0.082 | 0.057 | 0.082 | Transforming growth factor beta 3 antagonist | |||
| 0.039 | 0.014 | 0.043 | Protein kinase (CK2) beta inhibitor | 0.043 0.01 CID_51818 0.041 0.012 CID_154699680 | CID_51818 | |
| 0.061 | 0.036 | 0.061 | Botulinum neurotoxin type A inhibitor | |||
| 0.039 | 0.015 | 0.043 | Melatonin receptor 1A agonist | 0.043 0.011 CID_51818 | CID_51818 | |
| 0.044 | 0.02 | 0.047 | Glutamate (mGluR group II) antagonist | 0.047 0.018 CID_51818 | CID_51818 | |
| 0.127 | 0.103 | 0.127 | Thiol protease inhibitor | 0.126 0.103 CID_154699680 0.127 0.101 CID_154699962 | ||
| 0.045 | 0.022 | 0.045 | Heme oxygenase inhibitor | 0.042 0.032 CID_51818 | ||
| 0.111 | 0.088 | 0.195 | Toll-Like receptor 2 antagonist | 0.159 0.047 CID_51818 0.125 0.072 CID_154699680 0.195 0.026 CID_154699962 | CID_154699962 | |
| 0.042 | 0.019 | 0.042 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.056 | 0.033 | 0.056 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.047 | 0.025 | 0.047 | Histamine H2 receptor agonist | |||
| 0.041 | 0.019 | 0.041 | Vanilloid 3 antagonist | |||
| 0.068 | 0.046 | 0.068 | Acetylcholine M5 receptor agonist | |||
| 0.042 | 0.021 | 0.042 | Retinoid X receptor agonist | |||
| 0.193 | 0.173 | 0.193 | Immunomodulator | |||
| 0.028 | 0.008 | 0.03 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.019 0.014 CID_154699680 0.03 0.008 CID_154699962 | CID_154699962 | |
| 0.149 | 0.129 | 0.149 | Platelet aggregation inhibitor | |||
| 0.051 | 0.031 | 0.051 | Bromodomain-containing protein 3 inhibitor | |||
| 0.051 | 0.031 | 0.054 | AMPA receptor antagonist | 0.054 0.028 CID_51818 | CID_51818 | |
| 0.067 | 0.047 | 0.067 | Nav1.7 sodium channel blocker | |||
| 0.047 | 0.028 | 0.047 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.151 | 0.132 | 0.192 | Insulin sensitizer | 0.183 0.092 CID_51818 0.165 0.113 CID_154699680 0.192 0.082 CID_154699962 | CID_154699962 | |
| 0.049 | 0.03 | 0.049 | Aldosterone antagonist | |||
| 0.06 | 0.041 | 0.117 | Aromatase inhibitor | 0.085 0.025 CID_154699680 0.117 0.018 CID_154699962 | CID_154699962 | |
| 0.054 | 0.035 | 0.054 | 5 Hydroxytryptamine 1B agonist | 0.054 0.034 CID_154699962 | ||
| 0.055 | 0.036 | 0.058 | Protein kinase C epsilon inhibitor | 0.058 0.033 CID_154699962 | CID_154699962 | |
| 0.13 | 0.111 | 0.159 | Interferon gamma antagonist | 0.133 0.104 CID_51818 0.135 0.101 CID_13332617 0.153 0.073 CID_154699680 0.159 0.067 CID_154699962 | CID_154699962 | |
| 0.079 | 0.061 | 0.083 | I kappa B kinase inhibitor | 0.083 0.056 CID_51818 | CID_51818 | |
| 0.034 | 0.016 | 0.034 | Glutamate (mGluR2) antagonist | 0.033 0.016 CID_51818 | ||
| 0.025 | 0.007 | 0.025 | Retinoid X beta receptor antagonist | 0.021 0.013 CID_51818 0.023 0.01 CID_154699680 | ||
| 0.059 | 0.042 | 0.135 | Heat shock protein 90 beta antagonist | 0.135 0.005 CID_154699680 0.07 0.028 CID_154699962 | CID_154699680 | |
| 0.044 | 0.027 | 0.044 | Nerve growth factor antagonist | |||
| 0.097 | 0.079 | 0.097 | Protein kinase (CK2) alpha inhibitor | 0.09 0.087 CID_154699680 0.091 0.086 CID_154699962 | ||
| 0.046 | 0.029 | 0.088 | NMDA receptor subunit 3B antagonist | 0.042 0.033 CID_51818 0.064 0.018 CID_154699680 0.088 0.012 CID_154699962 | CID_154699962 | |
| 0.035 | 0.018 | 0.035 | Potassium channel small-conductance Ca-activated activator | |||
| 0.036 | 0.02 | 0.036 | Free fatty acid receptor 1 antagonist | 0.035 0.022 CID_51818 | ||
| 0.059 | 0.042 | 0.059 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.041 | 0.024 | 0.041 | MAP3K5 inhibitor | 0.037 0.032 CID_51818 | ||
| 0.036 | 0.019 | 0.036 | Calcium release-activated channel blocker | |||
| 0.079 | 0.063 | 0.079 | 5 Hydroxytryptamine 2C antagonist | 0.078 0.063 CID_154699962 | ||
| 0.045 | 0.029 | 0.045 | Histamine H1 receptor agonist | |||
| 0.043 | 0.028 | 0.043 | Cholecystokinin antagonist | |||
| 0.102 | 0.087 | 0.156 | Microtubule formation inhibitor | 0.13 0.051 CID_13332617 0.156 0.034 CID_154699962 | CID_154699962 | |
| 0.053 | 0.038 | 0.073 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.052 0.039 CID_51818 0.064 0.026 CID_154699680 0.073 0.02 CID_154699962 | CID_154699962 | |
| 0.027 | 0.012 | 0.027 | Complement factor 1s inhibitor | |||
| 0.118 | 0.103 | 0.118 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.033 | 0.019 | 0.033 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.055 | 0.04 | 0.067 | Alcohol oxidase inhibitor | 0.067 0.031 CID_51818 0.058 0.037 CID_154699680 0.064 0.032 CID_154699962 | CID_51818 | |
| 0.061 | 0.046 | 0.061 | 5 Hydroxytryptamine 2A agonist | |||
| 0.057 | 0.043 | 0.063 | Sphingosine 1-phosphate receptor 3 antagonist | 0.063 0.033 CID_51818 | CID_51818 | |
| 0.039 | 0.025 | 0.039 | Cholecystokinin A antagonist | |||
| 0.055 | 0.042 | 0.061 | Leukotriene C antagonist | 0.061 0.028 CID_51818 0.057 0.037 CID_154699680 | CID_51818 | |
| 0.129 | 0.116 | 0.18 | Melanin inhibitor | 0.134 0.106 CID_51818 0.142 0.093 CID_13332617 0.141 0.094 CID_154699680 0.18 0.052 CID_154699962 | CID_154699962 | |
| 0.089 | 0.076 | 0.11 | Alpha 2c adrenoreceptor antagonist | 0.11 0.057 CID_154699962 | CID_154699962 | |
| 0.08 | 0.067 | 0.084 | Myeloperoxidase inhibitor | 0.084 0.059 CID_51818 0.083 0.061 CID_154699962 | CID_51818 | |
| 0.03 | 0.017 | 0.03 | 5 Hydroxytryptamine 6 agonist | |||
| 0.055 | 0.042 | 0.055 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.074 | 0.062 | 0.103 | Interferon agonist | 0.103 0.026 CID_51818 | CID_51818 | |
| 0.027 | 0.015 | 0.027 | Complement factor 1r inhibitor | |||
| 0.096 | 0.085 | 0.194 | Interleukin 1b antagonist | 0.194 0.021 CID_154699962 | CID_154699962 | |
| 0.076 | 0.065 | 0.078 | Phosphodiesterase IV inhibitor | 0.078 0.064 CID_51818 | CID_51818 | |
| 0.034 | 0.023 | 0.038 | Angiotensin II receptor antagonist | 0.038 0.018 CID_51818 | CID_51818 | |
| 0.045 | 0.034 | 0.051 | Thymidylate synthase inhibitor | 0.051 0.026 CID_51818 0.048 0.03 CID_154699680 | CID_51818 | |
| 0.056 | 0.046 | 0.056 | Cyclin A1 inhibitor | |||
| 0.057 | 0.047 | 0.057 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.038 | 0.029 | 0.042 | GABA uptake inhibitor | 0.042 0.024 CID_51818 | CID_51818 | |
| 0.096 | 0.087 | 0.096 | MAP kinase 13 inhibitor | |||
| 0.07 | 0.061 | 0.07 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.046 | 0.037 | 0.066 | Glucose-6-phosphate isomerase inhibitor | 0.066 0.014 CID_51818 0.054 0.024 CID_13332617 | CID_51818 | |
| 0.06 | 0.052 | 0.06 | Phosphodiesterase III inhibitor | 0.059 0.053 CID_51818 | ||
| 0.038 | 0.03 | 0.045 | AMPA 4 receptor antagonist | 0.036 0.035 CID_51818 0.045 0.02 CID_154699962 | CID_154699962 | |
| 0.028 | 0.02 | 0.028 | Cyclin E2 inhibitor | 0.025 0.023 CID_51818 | ||
| 0.093 | 0.085 | 0.093 | Polo-like kinase-4 inhibitor | |||
| 0.037 | 0.029 | 0.041 | Urate transporter 1 inhibitor | 0.041 0.025 CID_51818 0.035 0.032 CID_154699680 | CID_51818 | |
| 0.073 | 0.066 | 0.094 | Phosphodiesterase 3A inhibitor | 0.094 0.038 CID_51818 | CID_51818 | |
| 0.081 | 0.074 | 0.144 | Potassium channel (Ca-activated) activator | 0.08 0.075 CID_154699680 0.144 0.03 CID_154699962 | CID_154699962 | |
| 0.058 | 0.051 | 0.061 | I kappa B kinase 2 inhibitor | 0.061 0.045 CID_51818 | CID_51818 | |
| 0.013 | 0.006 | 0.013 | Imidazoline I2 receptor antagonist | |||
| 0.079 | 0.072 | 0.084 | Estrogen-related receptor beta agonist | 0.084 0.056 CID_154699680 0.081 0.063 CID_154699962 | CID_154699680 | |
| 0.105 | 0.098 | 0.14 | Cyclooxygenase 2 inhibitor | 0.14 0.062 CID_154699962 | CID_154699962 | |
| 0.107 | 0.101 | 0.252 | NADPH oxidase inhibitor | 0.113 0.092 CID_154699680 0.252 0.02 CID_154699962 | CID_154699962 | |
| 0.028 | 0.021 | 0.054 | Liver X receptor beta antagonist | 0.054 0.007 CID_51818 | CID_51818 | |
| 0.046 | 0.039 | 0.046 | Histamine H4 receptor antagonist | |||
| 0.054 | 0.048 | 0.054 | Cannabinoid CB1 receptor agonist | |||
| 0.076 | 0.069 | 0.085 | Phosphodiesterase XI inhibitor | 0.085 0.05 CID_154699962 | CID_154699962 | |
| 0.076 | 0.069 | 0.085 | Phosphodiesterase 11A inhibitor | 0.085 0.05 CID_154699962 | CID_154699962 | |
| 0.02 | 0.014 | 0.024 | Toll-Like receptor 8 agonist | 0.024 0.008 CID_51818 | CID_51818 | |
| 0.051 | 0.045 | 0.087 | Glucosylceramidase inhibitor | 0.087 0.012 CID_51818 0.065 0.025 CID_13332617 | CID_51818 | |
| 0.038 | 0.032 | 0.038 | Glutamate (mGluR1a) antagonist | |||
| 0.028 | 0.023 | 0.028 | Complement C5a chemotactic receptor antagonist | |||
| 0.07 | 0.065 | 0.071 | Vanilloid 4 agonist | 0.071 0.061 CID_51818 | CID_51818 | |
| 0.094 | 0.09 | 0.094 | Aurora-B kinase inhibitor | |||
| 0.084 | 0.08 | 0.085 | MAP kinase kinase 1 inhibitor | 0.085 0.079 CID_51818 | CID_51818 | |
| 0.143 | 0.139 | 0.143 | Anticonvulsant | |||
| 0.217 | 0.213 | 0.233 | DNA polymerase beta inhibitor | 0.233 0.203 CID_154699680 | CID_154699680 | |
| 0.109 | 0.105 | 0.297 | Lipid peroxidase inhibitor | 0.161 0.061 CID_13332617 0.208 0.039 CID_154699680 0.297 0.019 CID_154699962 | CID_154699962 | |
| 0.01 | 0.006 | 0.01 | Progesterone receptor A antagonist | 0.009 0.007 CID_154699962 | ||
| 0.059 | 0.056 | 0.081 | Interferon inducer | 0.081 0.023 CID_51818 | CID_51818 | |
| 0.034 | 0.03 | 0.034 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.039 | 0.036 | 0.043 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.043 0.026 CID_154699680 | CID_154699680 | |
| 0.064 | 0.06 | 0.064 | Exportin-1 inhibitor | |||
| 0.09 | 0.086 | 0.157 | AMP-activated protein kinase stimulant | 0.131 0.04 CID_51818 0.105 0.064 CID_154699680 0.157 0.024 CID_154699962 | CID_154699962 | |
| 0.145 | 0.142 | 0.145 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.076 | 0.073 | 0.091 | Thioredoxin reductase inhibitor | 0.091 0.039 CID_51818 0.086 0.048 CID_154699680 | CID_51818 | |
| 0.026 | 0.023 | 0.026 | Glucosylceramidase stimulant | |||
| 0.022 | 0.019 | 0.022 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.033 | 0.031 | 0.067 | NMDA receptor subunit 3A antagonist | 0.049 0.02 CID_154699680 0.067 0.015 CID_154699962 | CID_154699962 | |
| 0.03 | 0.029 | 0.03 | ATR kinase inhibitor | |||
| 0.066 | 0.065 | 0.066 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.043 | 0.041 | 0.044 | Phosphodiesterase 4A inhibitor | 0.044 0.04 CID_51818 | CID_51818 | |
| 0.097 | 0.096 | 0.102 | Caspase 3 inhibitor | 0.102 0.089 CID_51818 0.101 0.091 CID_154699680 0.101 0.091 CID_154699962 | CID_51818 | |
| 0.009 | 0.008 | 0.009 | Corticotropin releasing factor antagonist | |||
| 0.111 | 0.11 | 0.121 | Vanilloid 1 agonist | 0.119 0.09 CID_51818 0.121 0.086 CID_154699962 | CID_154699962 | |
| 0.047 | 0.047 | 0.062 | Acyl-CoA dehydrogenase inhibitor | 0.062 0.032 CID_51818 | CID_51818 | |
| 0.085 | 0.084 | 0.147 | Urease inhibitor | 0.147 0.024 CID_154699962 | CID_154699962 | |
| 0.056 | 0.056 | 0.063 | Bcl-xL inhibitor | 0.056 0.053 CID_51818 0.063 0.033 CID_154699680 | CID_154699680 | |
| 0.054 | 0.055 | 0.198 | HIV-1 integrase (3'-Processing) inhibitor | 0.073 0.037 CID_13332617 0.18 0.011 CID_154699680 0.198 0.01 CID_154699962 | CID_154699962 | |
| 0.035 | 0.036 | 0.039 | Retinoic acid alpha receptor agonist | 0.039 0.027 CID_51818 | CID_51818 | |
| 0.052 | 0.053 | 0.082 | Carbamoyl phosphate synthetase inhibitor | 0.082 0.027 CID_51818 | CID_51818 | |
| 0.11 | 0.112 | 0.152 | Cyclooxygenase inhibitor | 0.152 0.069 CID_154699962 | CID_154699962 | |
| 0.036 | 0.039 | 0.04 | Leukotriene C4 antagonist | 0.04 0.025 CID_51818 | CID_51818 | |
| 0.047 | 0.05 | 0.091 | Xanthine dehydrogenase inhibitor | 0.081 0.024 CID_51818 0.091 0.019 CID_154699680 0.085 0.022 CID_154699962 | CID_154699680 | |
| 0.084 | 0.087 | 0.109 | Gastric antisecretory | 0.109 0.054 CID_13332617 | CID_13332617 | |
| 0.017 | 0.02 | 0.027 | Adenosine kinase inhibitor | 0.027 0.012 CID_51818 | CID_51818 | |
| 0.051 | 0.055 | 0.057 | Bombesin 1 receptor agonist | 0.057 0.045 CID_154699962 | CID_154699962 | |
| 0.06 | 0.064 | 0.076 | Prostaglandin-E synthase inhibitor | 0.076 0.042 CID_154699962 | CID_154699962 | |
| 0.045 | 0.049 | 0.082 | CD45 antagonist | 0.048 0.039 CID_51818 0.082 0.012 CID_154699962 | CID_154699962 | |
| 0.062 | 0.067 | 0.068 | MDM2 inhibitor | 0.068 0.043 CID_51818 0.066 0.052 CID_154699962 | CID_51818 | |
| 0.117 | 0.122 | 0.145 | Phospholipase A2 inhibitor | 0.145 0.079 CID_154699680 | CID_154699680 | |
| 0.106 | 0.111 | 0.176 | Protein kinase stimulant | 0.176 0.052 CID_51818 0.112 0.102 CID_13332617 | CID_51818 | |
| 0.062 | 0.068 | 0.087 | Na+ K+ transporting ATPase inhibitor | 0.081 0.049 CID_51818 0.067 0.063 CID_154699680 0.087 0.044 CID_154699962 | CID_154699962 | |
| 0.042 | 0.05 | 0.054 | mTOR inhibitor | 0.054 0.034 CID_51818 | CID_51818 | |
| 0.059 | 0.066 | 0.085 | Catalase inhibitor | 0.085 0.045 CID_51818 | CID_51818 | |
| 0.077 | 0.085 | 0.085 | Aminopeptidase B inhibitor | 0.085 0.077 CID_51818 | CID_51818 | |
| 0.026 | 0.034 | 0.066 | Progesterone antagonist | 0.066 0.013 CID_154699962 | CID_154699962 | |
| 0.062 | 0.07 | 0.075 | Glutamate dehydrogenase inhibitor | 0.075 0.049 CID_51818 | CID_51818 | |
| 0.094 | 0.102 | 0.101 | MAP kinase kinase inhibitor | 0.101 0.094 CID_51818 | CID_51818 | |
| 0.048 | 0.057 | 0.056 | Dihydroorotate oxidase inhibitor | 0.056 0.036 CID_154699962 | CID_154699962 | |
| 0.045 | 0.054 | 0.056 | Argininosuccinate synthase inhibitor | 0.056 0.04 CID_51818 | CID_51818 | |
| 0.033 | 0.042 | 0.05 | Liver X receptor alpha agonist | 0.05 0.019 CID_51818 | CID_51818 | |
| 0.054 | 0.064 | 0.11 | Phosphofructokinase-1 inhibitor | 0.11 0.028 CID_51818 | CID_51818 | |
| 0.07 | 0.081 | 0.086 | Inducible nitric-oxide synthase inhibitor | 0.086 0.053 CID_154699962 | CID_154699962 | |
| 0.045 | 0.056 | 0.087 | Cyclin B2 inhibitor | 0.087 0.012 CID_154699962 | CID_154699962 | |
| 0.032 | 0.043 | 0.054 | Dopamine D5 agonist | 0.048 0.019 CID_154699680 0.054 0.015 CID_154699962 | CID_154699962 | |
| 0.025 | 0.037 | 0.029 | ATP citrate lysase inhibitor | 0.029 0.028 CID_154699680 | CID_154699680 | |
| 0.027 | 0.04 | 0.037 | RNA-directed RNA polymerase inhibitor | 0.037 0.02 CID_154699962 | CID_154699962 | |
| 0.024 | 0.038 | 0.043 | Kainate receptor 2 antagonist | 0.043 0.02 CID_154699962 | CID_154699962 | |
| 0.025 | 0.039 | 0.038 | Liver X receptor beta agonist | 0.038 0.017 CID_51818 | CID_51818 | |
| 0.031 | 0.047 | 0.036 | Glutamate (mGluR8) agonist | 0.036 0.031 CID_51818 | CID_51818 | |
| 0.079 | 0.095 | 0.169 | Xanthine oxidase inhibitor | 0.099 0.061 CID_51818 0.101 0.059 CID_154699680 0.169 0.028 CID_154699962 | CID_154699962 | |
| 0.022 | 0.039 | 0.035 | HCV NS5B polymerase inhibitor | 0.035 0.018 CID_154699962 | CID_154699962 | |
| 0.131 | 0.15 | 0.171 | Phospholipase C inhibitor | 0.162 0.085 CID_51818 0.144 0.119 CID_154699680 0.171 0.071 CID_154699962 | CID_154699962 | |
| 0.089 | 0.108 | 0.121 | CDC-like kinase 3 inhibitor | 0.121 0.042 CID_154699962 | CID_154699962 | |
| 0.028 | 0.047 | 0.034 | Glutamate (mGluR3) antagonist | 0.034 0.03 CID_51818 | CID_51818 | |
| 0.075 | 0.095 | 0.102 | Sphingomyelinase inhibitor | 0.102 0.058 CID_51818 | CID_51818 | |
| 0.083 | 0.103 | 0.133 | Adenylate cyclase inhibitor | 0.133 0.057 CID_51818 0.107 0.078 CID_154699962 | CID_51818 | |
| 0.024 | 0.045 | 0.042 | Phosphoglycerate kinase inhibitor | 0.042 0.018 CID_51818 | CID_51818 | |
| 0.101 | 0.122 | 0.235 | Interleukin 1 antagonist | 0.131 0.075 CID_154699680 0.235 0.022 CID_154699962 | CID_154699962 | |
| 0.041 | 0.064 | 0.078 | Cyclin B inhibitor | 0.078 0.016 CID_154699962 | CID_154699962 | |
| 0.063 | 0.086 | 0.192 | Carbonic anhydrase VI inhibitor | 0.099 0.04 CID_51818 0.192 0.014 CID_154699962 | CID_154699962 | |
| 0.085 | 0.108 | 0.181 | MAO inhibitor | 0.136 0.067 CID_154699680 0.181 0.047 CID_154699962 | CID_154699962 | |
| 0.034 | 0.058 | 0.038 | CF transmembrane conductance regulator antagonist | 0.038 0.032 CID_51818 | CID_51818 | |
| 0.02 | 0.045 | 0.025 | Thymidine phosphorylase inhibitor | 0.025 0.022 CID_51818 | CID_51818 | |
| 0.043 | 0.067 | 0.066 | Sphingosine kinase 2 inhibitor | 0.066 0.026 CID_51818 | CID_51818 | |
| 0.051 | 0.077 | 0.154 | Histidine decarboxylase inhibitor | 0.154 0.019 CID_51818 0.064 0.058 CID_154699962 | CID_51818 | |
| 0.056 | 0.082 | 0.081 | Alpha 2a adrenoreceptor antagonist | 0.081 0.048 CID_154699962 | CID_154699962 | |
| 0.054 | 0.08 | 0.081 | Glutamate decarboxylase inhibitor | 0.066 0.06 CID_154699680 0.081 0.043 CID_154699962 | CID_154699962 | |
| 0.054 | 0.081 | 0.065 | Cathepsin G inhibitor | 0.065 0.06 CID_51818 | CID_51818 | |
| 0.097 | 0.123 | 0.117 | Alkaline phosphatase inhibitor | 0.117 0.089 CID_154699962 | CID_154699962 | |
| 0.061 | 0.088 | 0.076 | Keratolytic | 0.076 0.054 CID_51818 0.07 0.064 CID_154699962 | CID_51818 | |
| 0.013 | 0.04 | 0.037 | Estrogen receptor beta agonist | 0.037 0.022 CID_154699680 | CID_154699680 | |
| 0.056 | 0.084 | 0.133 | MAP-kinase-activated kinase 2 inhibitor | 0.133 0.015 CID_154699962 | CID_154699962 | |
| 0.244 | 0.273 | 0.656 | Antiinflammatory | 0.656 0.039 CID_51818 0.618 0.049 CID_13332617 0.351 0.172 CID_154699680 0.334 0.185 CID_154699962 | CID_51818 | |
| 0.034 | 0.064 | 0.059 | Carbonic anhydrase VB inhibitor | 0.059 0.036 CID_51818 | CID_51818 | |
| 0.017 | 0.048 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.019 CID_51818 0.024 0.023 CID_13332617 | CID_51818 | |
| 0.06 | 0.091 | 0.089 | Protein kinase A inhibitor | 0.089 0.053 CID_154699962 | CID_154699962 | |
| 0.041 | 0.073 | 0.06 | NMDA receptor glycine site agonist | 0.06 0.046 CID_154699962 | CID_154699962 | |
| 0.063 | 0.095 | 0.149 | MAP-kinase-activated kinase inhibitor | 0.149 0.015 CID_154699962 | CID_154699962 | |
| 0.083 | 0.117 | 0.216 | Amylase inhibitor | 0.191 0.047 CID_51818 0.116 0.084 CID_154699680 0.216 0.039 CID_154699962 | CID_154699962 | |
| 0.129 | 0.165 | 0.218 | Catenin beta inhibitor | 0.178 0.055 CID_154699680 0.218 0.021 CID_154699962 | CID_154699962 | |
| 0.051 | 0.089 | 0.089 | Beta 3 adrenoreceptor antagonist | 0.06 0.055 CID_51818 0.089 0.018 CID_154699962 | CID_154699962 | |
| 0.08 | 0.118 | 0.115 | Cholesterol synthesis inhibitor | 0.115 0.07 CID_13332617 | CID_13332617 | |
| 0.017 | 0.059 | 0.024 | Sodium/glucose cotransporter inhibitor | 0.024 0.023 CID_51818 | CID_51818 | |
| 0.13 | 0.176 | 0.427 | Free radical scavenger | 0.162 0.131 CID_13332617 0.332 0.043 CID_154699680 0.427 0.025 CID_154699962 | CID_154699962 | |
| 0.016 | 0.063 | 0.026 | Thyroid hormone agonist | 0.026 0.018 CID_154699962 | CID_154699962 | |
| 0.039 | 0.087 | 0.085 | Cyclin B1 inhibitor | 0.085 0.018 CID_154699962 | CID_154699962 | |
| 0.011 | 0.06 | 0.032 | Kainate receptor 4 antagonist | 0.032 0.013 CID_154699962 | CID_154699962 | |
| 0.11 | 0.161 | 0.135 | Amyloid beta precursor protein antagonist | 0.135 0.12 CID_154699680 | CID_154699680 | |
| 0.031 | 0.082 | 0.078 | Alpha tubulin antagonist | 0.059 0.031 CID_154699680 0.078 0.02 CID_154699962 | CID_154699962 | |
| 0.053 | 0.105 | 0.077 | GABA aminotransferase inhibitor | 0.074 0.055 CID_154699680 0.077 0.05 CID_154699962 | CID_154699962 | |
| 0.095 | 0.148 | 0.13 | Cell wall synthesis inhibitor | 0.13 0.086 CID_51818 | CID_51818 | |
| 0.113 | 0.165 | 0.129 | CC chemokine 6 receptor antagonist | 0.125 0.091 CID_154699680 0.129 0.075 CID_154699962 | CID_154699962 | |
| 0.024 | 0.077 | 0.053 | Adenosine deaminase inhibitor | 0.053 0.027 CID_51818 | CID_51818 | |
| 0.02 | 0.075 | 0.061 | Estrogen agonist | 0.061 0.03 CID_154699680 | CID_154699680 | |
| 0.021 | 0.079 | 0.034 | Protein kinase C beta II inhibitor | 0.034 0.019 CID_154699962 | CID_154699962 | |
| 0.014 | 0.073 | 0.039 | Liver X receptor antagonist | 0.039 0.014 CID_51818 | CID_51818 | |
| 0.012 | 0.071 | 0.042 | Dopamine D1 agonist | 0.042 0.005 CID_154699680 0.038 0.006 CID_154699962 | CID_154699680 | |
| 0.015 | 0.075 | 0.038 | Liver X receptor alpha antagonist | 0.038 0.01 CID_51818 | CID_51818 | |
| 0.071 | 0.131 | 0.088 | Toll-Like receptor 3 antagonist | 0.088 0.074 CID_154699962 | CID_154699962 | |
| 0.024 | 0.085 | 0.067 | Acid-sensing ion channel blocker | 0.067 0.007 CID_154699962 | CID_154699962 | |
| 0.066 | 0.127 | 0.091 | Thioredoxin inhibitor | 0.084 0.073 CID_51818 0.091 0.061 CID_154699680 0.085 0.071 CID_154699962 | CID_154699680 | |
| 0.054 | 0.116 | 0.077 | NMDA receptor antagonist | 0.077 0.07 CID_154699962 | CID_154699962 | |
| 0.161 | 0.224 | 0.222 | Vasodilator, coronary | 0.217 0.167 CID_51818 0.222 0.162 CID_154699962 | CID_154699962 | |
| 0.041 | 0.108 | 0.074 | Carbonic anhydrase XIII inhibitor | 0.074 0.055 CID_51818 | CID_51818 | |
| 0.037 | 0.107 | 0.083 | Dopamine D1 antagonist | 0.063 0.047 CID_154699680 0.083 0.032 CID_154699962 | CID_154699962 | |
| 0.047 | 0.119 | 0.198 | HIV-1 integrase inhibitor | 0.063 0.061 CID_13332617 0.198 0.005 CID_154699680 0.137 0.011 CID_154699962 | CID_154699680 | |
| 0.069 | 0.143 | 0.101 | Mucolytic | 0.101 0.076 CID_51818 | CID_51818 | |
| 0.038 | 0.112 | 0.054 | Sphingosine kinase inhibitor | 0.054 0.052 CID_51818 | CID_51818 | |
| 0.029 | 0.105 | 0.146 | HIV-1 integrase (Strand Transfer) inhibitor | 0.107 0.02 CID_13332617 0.124 0.016 CID_154699680 0.146 0.013 CID_154699962 | CID_154699962 | |
| 0.065 | 0.142 | 0.079 | Hematopoietic | 0.079 0.077 CID_51818 | CID_51818 | |
| 0.116 | 0.193 | 0.208 | Immunostimulant | 0.208 0.116 CID_51818 0.17 0.139 CID_154699680 0.161 0.145 CID_154699962 | CID_51818 | |
| 0.097 | 0.173 | 0.121 | Growth hormone agonist | 0.121 0.12 CID_154699962 | CID_154699962 | |
| 0.026 | 0.105 | 0.056 | Bruton tyrosine kinase inhibitor | 0.056 0.04 CID_51818 | CID_51818 | |
| 0.021 | 0.101 | 0.12 | Beta tubulin antagonist | 0.068 0.035 CID_154699680 0.12 0.017 CID_154699962 | CID_154699962 | |
| 0.041 | 0.122 | 0.103 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.103 0.034 CID_154699962 | CID_154699962 | |
| 0.103 | 0.186 | 0.143 | Death-associated protein kinase 1 inhibitor | 0.143 0.051 CID_154699962 | CID_154699962 | |
| 0.047 | 0.132 | 0.102 | Cyclin-dependent kinase 1 inhibitor | 0.102 0.065 CID_154699962 | CID_154699962 | |
| 0.046 | 0.131 | 0.274 | CDC25A inhibitor | 0.169 0.01 CID_154699680 0.274 0.004 CID_154699962 | CID_154699962 | |
| 0.045 | 0.132 | 0.084 | Somatostatin 1 agonist | 0.084 0.047 CID_51818 | CID_51818 | |
| 0.018 | 0.109 | 0.034 | Ceramide glucosyltransferase inhibitor | 0.034 0.027 CID_51818 | CID_51818 | |
| 0.052 | 0.144 | 0.119 | Mediator release inhibitor | 0.119 0.049 CID_154699680 0.102 0.067 CID_154699962 | CID_154699680 | |
| 0.154 | 0.245 | 0.229 | Antithrombotic | 0.229 0.145 CID_51818 | CID_51818 | |
| 0.024 | 0.119 | 0.064 | Beta 2 adrenoreceptor antagonist | 0.064 0.021 CID_154699962 | CID_154699962 | |
| 0.034 | 0.129 | 0.101 | Check point kinase 1 inhibitor | 0.101 0.028 CID_154699962 | CID_154699962 | |
| 0.055 | 0.151 | 0.104 | Uric acid excretion stimulant | 0.104 0.049 CID_51818 | CID_51818 | |
| 0.025 | 0.122 | 0.072 | Beta 1 adrenoreceptor antagonist | 0.072 0.025 CID_154699962 | CID_154699962 | |
| 0.096 | 0.196 | 0.353 | Interleukin antagonist | 0.149 0.119 CID_154699680 0.353 0.038 CID_154699962 | CID_154699962 | |
| 0.098 | 0.2 | 0.298 | Antimitotic | 0.191 0.089 CID_154699680 0.298 0.044 CID_154699962 | CID_154699962 | |
| 0.027 | 0.129 | 0.051 | Alpha-mannosidase inhibitor | 0.051 0.042 CID_51818 | CID_51818 | |
| 0.052 | 0.165 | 0.178 | M18 aspartyl aminopeptidase inhibitor | 0.178 0.04 CID_154699680 0.141 0.057 CID_154699962 | CID_154699680 | |
| 0.041 | 0.156 | 0.158 | Monophenol monooxygenase inhibitor | 0.158 0.044 CID_154699962 | CID_154699962 | |
| 0.044 | 0.16 | 0.062 | Beta 2 adrenoreceptor agonist | 0.062 0.04 CID_51818 | CID_51818 | |
| 0.103 | 0.219 | 0.177 | Lipocortins synthesis antagonist | 0.151 0.103 CID_13332617 0.177 0.073 CID_154699962 | CID_154699962 | |
| 0.146 | 0.268 | 0.334 | Alpha-glucosidase inhibitor | 0.247 0.189 CID_154699680 0.334 0.144 CID_154699962 | CID_154699962 | |
| 0.032 | 0.156 | 0.072 | Beta adrenoreceptor antagonist | 0.072 0.035 CID_154699962 | CID_154699962 | |
| 0.031 | 0.158 | 0.217 | CDC25B inhibitor | 0.097 0.017 CID_154699680 0.217 0.004 CID_154699962 | CID_154699962 | |
| 0.059 | 0.186 | 0.118 | Cyclooxygenase 1 inhibitor | 0.118 0.083 CID_154699962 | CID_154699962 | |
| 0.087 | 0.22 | 0.209 | Dual specificity phosphatase inhibitor | 0.208 0.051 CID_154699680 0.209 0.05 CID_154699962 | CID_154699962 | |
| 0.099 | 0.255 | 0.377 | Antioxidant | 0.16 0.154 CID_51818 0.224 0.099 CID_13332617 0.31 0.058 CID_154699680 0.377 0.039 CID_154699962 | CID_154699962 | |
| 0.037 | 0.192 | 0.072 | Adrenaline agonist | 0.072 0.069 CID_51818 | CID_51818 | |
| 0.07 | 0.232 | 0.188 | Dual specificity phosphatase 3 inhibitor | 0.188 0.068 CID_154699680 0.127 0.12 CID_154699962 | CID_154699680 | |
| 0.058 | 0.222 | 0.086 | Interleukin 12 antagonist | 0.086 0.082 CID_154699962 | CID_154699962 | |
| 0.023 | 0.199 | 0.077 | Leukotriene synthesis inhibitor | 0.077 0.039 CID_51818 | CID_51818 | |
| 0.05 | 0.227 | 0.084 | Interleukin 5 antagonist | 0.084 0.065 CID_51818 | CID_51818 | |
| 0.032 | 0.233 | 0.229 | 5-Lipoxygenase inhibitor | 0.112 0.055 CID_154699680 0.229 0.019 CID_154699962 | CID_154699962 | |
| 0.015 | 0.223 | 0.03 | Elastase 2B inhibitor | 0.03 0.021 CID_154699962 | CID_154699962 | |
| 0.015 | 0.223 | 0.03 | Elastase 3B inhibitor | 0.03 0.021 CID_154699962 | CID_154699962 | |
| 0.015 | 0.223 | 0.03 | Elastase 3A inhibitor | 0.03 0.021 CID_154699962 | CID_154699962 | |
| 0.023 | 0.25 | 0.061 | Elastase 1 inhibitor | 0.061 0.06 CID_154699962 | CID_154699962 | |
| 0.03 | 0.267 | 0.069 | Potassium channel large-conductance Ca-activated activator | 0.069 0.045 CID_154699962 | CID_154699962 | |
| 0.01 | 0.273 | 0.142 | Antineoplastic antibiotic | 0.142 0.033 CID_13332617 0.082 0.056 CID_154699680 0.096 0.048 CID_154699962 | CID_13332617 | |
| 0.033 | 0.335 | 0.189 | Protein-tyrosine phosphatase inhibitor | 0.134 0.096 CID_154699680 0.189 0.051 CID_154699962 | CID_154699962 | |
| 0.027 | 0.331 | 0.159 | Bronchodilator | 0.159 0.029 CID_51818 | CID_51818 | |
| 0.011 | 0.33 | 0.081 | Dopamine agonist | 0.066 0.047 CID_154699680 0.081 0.036 CID_154699962 | CID_154699962 | |
| 0.071 | 0.402 | 0.174 | Hypoglycemic | 0.174 0.142 CID_154699962 | CID_154699962 | |
| 0.006 | 0.344 | 0.046 | Catechol O-methyltransferase inhibitor | 0.046 0.01 CID_154699962 | CID_154699962 | |
| 0.054 | 0.393 | 0.198 | Tumour necrosis factor alpha release inhibitor | 0.198 0.111 CID_154699962 | CID_154699962 | |
| 0.013 | 0.371 | 0.099 | Protein-tyrosine phosphatase 1B inhibitor | 0.099 0.079 CID_154699962 | CID_154699962 | |
| 0.043 | 0.421 | 0.15 | Nitric oxide antagonist | 0.129 0.12 CID_13332617 0.131 0.117 CID_154699680 0.15 0.095 CID_154699962 | CID_154699962 | |
| 0.08 | 0.46 | 0.25 | Sodium/bile acid cotransporter inhibitor | 0.205 0.181 CID_13332617 0.215 0.168 CID_154699680 0.25 0.128 CID_154699962 | CID_154699962 | |
| 0.071 | 0.482 | 0.537 | Toll-Like receptor 7 agonist | 0.537 0.025 CID_51818 | CID_51818 | |
| 0.069 | 0.483 | 0.55 | Toll-Like receptor agonist | 0.55 0.023 CID_51818 | CID_51818 | |
| 0.022 | 0.453 | 0.289 | Chelator | 0.289 0.012 CID_154699962 | CID_154699962 | |
| 0.027 | 0.474 | 0.151 | Angiogenesis stimulant | 0.151 0.122 CID_154699962 | CID_154699962 | |
| 0.017 | 0.507 | 0.148 | ATPase (Vacuolar H+) inhibitor | 0.148 0.008 CID_13332617 | CID_13332617 | |
| 0.029 | 0.522 | 0.061 | Prolactin release inhibitor | 0.061 0.049 CID_51818 | CID_51818 | |
| 0.029 | 0.601 | 0.085 | Transcription factor NF kappa B stimulant | 0.085 0.058 CID_51818 | CID_51818 | |
| 0.022 | 0.631 | 0.117 | DNA polymerase I inhibitor | 0.117 0.07 CID_154699962 | CID_154699962 | |
| 0.051 | 0.814 | 0.307 | Interleukin 2 agonist | 0.307 0.069 CID_51818 | CID_51818 | |
| 0.047 | 0.928 | 0.198 | Peptidyltransferase inhibitor | 0.198 0.102 CID_13332617 | CID_13332617 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |